N-acetylglutamate Synthase: Structure, Function & Defects

N-乙酰谷氨酸合成酶:结构、功能

基本信息

  • 批准号:
    7809804
  • 负责人:
  • 金额:
    $ 55.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a Competitive Revision Application in response to the Recovery Act Funds Notice Number NOT-OD-09- 058. The parent project over goal is to explore the biology, biochemistry and pathophysiology of N- acetylglutamate synthase (NAGS) is an enzyme that produces the cognate cofactor N-acetylglutamate (NAG), an essential allosteric activator in ureagenesis. This revision application adds two new aims to the parent project. 1. To develop a knockout mouse for NAGS deficiency, characterize its phenotype, and explore its use as a conditional hyperammonemia model. 2. To "isolate" and study the in vivo regulation of ureagenesis specifically at the level of NAGS/CPSI by comparing nitrogen metabolism in N-carbamylglutamate (NCG) treated koNAGS mouse vs. wild type littermates. In addition to these new aims to be completed in two years, this project will enhance in the long term two of the existing aims that study the arginine effects on NAGS function and the effect of naturally-occurring mutations in patients with NAGS deficiency. In this revised project, we will develop, study and make available to the research community a novel "titratable mouse model of hyperammonemia. This knockout NAGS mouse will be rescued with NCG and will develop hyperammonemia upon withdrawal of this cofactor analog. We will determine the in vivo differences between nitrogen balance and metabolism in the NAGS "regulation-deprived" koNAGS mice rescued with NCG vs. the naturally-regulated wild type littermates on and off NCG. These studies will use both gene expression and protein profiles methods and will allow for the first time to "isolate" in vivo the regulatory effects of NAGS on ureagenesis. This project will enhance the pace and quality of the parent grant by providing a new tool for in vivo investigations for our group and other investigators studying hyperammonemia. In addition, The contribution of this project to the economy is leveraged by making the koNGAS mouse model available to othr investigators across the country, enhancing their research and promoting new job creation. PUBLIC HEALTH RELEVANCE: This project is dedicated to the investigation of an important gene and protein (NAGS) that determined how much nitrogen we eliminate from our bodies. It is important to know this since one of the main problem in liver disease is the inability to eliminate toxic nitrogen (ammonia) which can poison the brain. We will study an engineered mouse that does not posses NAGS to allow us to better understand this system and how it is regulated. The results from this project could allow the development of new treatments for elevated ammonia levels to protect the brain from its toxic effects.
描述(由申请人提供):这是一个竞争性修订申请,以回应复苏法基金通知编号NOT-OD-09- 058。本项目的目标是探索N-乙酰谷氨酸合酶(NAGS)的生物学、生物化学和病理生理学,NAGS是一种产生同源辅因子N-乙酰谷氨酸(NAG)的酶,NAG是尿素生成中必不可少的变构激活剂。此修订应用程序向父项目添加了两个新目标。1.开发NAGS缺陷基因敲除小鼠,表征其表型,并探索其作为条件性高氨血症模型的用途。2.通过比较N-氨甲酰谷氨酸(NCG)处理的koNAGS小鼠与野生型同窝小鼠的氮代谢,“分离”并研究体内尿素生成的调节,特别是在NAGS/CPSI水平。除了将在两年内完成的这些新目标外,该项目还将长期加强两个现有目标,即研究精氨酸对NAGS功能的影响以及NAGS缺乏症患者中天然突变的影响。在这个修订后的项目中,我们将开发、研究并向研究界提供一种新的“可滴定的高氨血症小鼠模型”。该敲除NAGS小鼠将用NCG拯救,并且在停用该辅因子类似物后将发展高氨血症。我们将确定用NCG拯救的NAGS“调节剥夺”koNAGS小鼠与自然调节的野生型同窝仔在NCG和非NCG下的氮平衡和代谢之间的体内差异。这些研究将使用基因表达和蛋白质谱的方法,并将允许第一次在体内“隔离”NAGS对尿素生成的调节作用。该项目将通过为我们组和其他研究高氨血症的研究者提供体内研究的新工具来提高母基金的速度和质量。此外,该项目对经济的贡献是通过使koNGAS小鼠模型提供给全国各地的研究人员,加强他们的研究和促进新的就业机会的创造。 公共卫生关系:该项目致力于研究一种重要的基因和蛋白质(NAGS),该基因和蛋白质决定了我们从体内消除多少氮。了解这一点很重要,因为肝病的主要问题之一是无法消除有毒的氮(氨),这可能会毒害大脑。我们将研究一种不含NAGS的工程小鼠,以使我们更好地了解这个系统及其如何调节。该项目的结果可以允许开发针对氨水平升高的新治疗方法,以保护大脑免受其毒性影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mendel Tuchman其他文献

Mendel Tuchman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mendel Tuchman', 18)}}的其他基金

Overall Adminstration of Rare Diseases Clinical Research Consortia (RDCRC)
罕见病临床研究联盟(RDCRC)的总体管理
  • 批准号:
    8916167
  • 财政年份:
    2015
  • 资助金额:
    $ 55.88万
  • 项目类别:
Pilot/Demonstration Clinical Research Projects Program
试点/示范临床研究项目计划
  • 批准号:
    8916164
  • 财政年份:
    2015
  • 资助金额:
    $ 55.88万
  • 项目类别:
N-acetylglutamate Synthase: Structure, Function & Defects
N-乙酰谷氨酸合成酶:结构、功能
  • 批准号:
    8035600
  • 财政年份:
    2010
  • 资助金额:
    $ 55.88万
  • 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
  • 批准号:
    8061384
  • 财政年份:
    2010
  • 资助金额:
    $ 55.88万
  • 项目类别:
N-CARBAMYLGLUTAMATE (CARBAGLU) IN THE TREATMENT OF HYPERAMMONEMIA
N-氨甲酰谷氨酸(CARBAGLU)治疗高氨血症
  • 批准号:
    8167358
  • 财政年份:
    2010
  • 资助金额:
    $ 55.88万
  • 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
  • 批准号:
    7848468
  • 财政年份:
    2009
  • 资助金额:
    $ 55.88万
  • 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
  • 批准号:
    7505006
  • 财政年份:
    2008
  • 资助金额:
    $ 55.88万
  • 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
  • 批准号:
    8254226
  • 财政年份:
    2008
  • 资助金额:
    $ 55.88万
  • 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
  • 批准号:
    7667880
  • 财政年份:
    2008
  • 资助金额:
    $ 55.88万
  • 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
  • 批准号:
    9036417
  • 财政年份:
    2008
  • 资助金额:
    $ 55.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了